SB2013 L04gr5: Difference between revisions
Emma Brower (talk | contribs) No edit summary |
Julia Joseph (talk | contribs) No edit summary |
||
| Line 66: | Line 66: | ||
10.<ref name="Chandra">Chandra A, Latov N, Wormser G, Marques A, Alaedini A. 2011. Epitope mapping of antibodies to VlsE protein of ''Borrelia burgdorferi'' in post-Lyme disease syndrome. Clinical Immunology. 141(1): 103-110. PMID[http://www.ncbi.nlm.nih.gov/pubmed/21778118 21778118]</ref> | 10.<ref name="Chandra">Chandra A, Latov N, Wormser G, Marques A, Alaedini A. 2011. Epitope mapping of antibodies to VlsE protein of ''Borrelia burgdorferi'' in post-Lyme disease syndrome. Clinical Immunology. 141(1): 103-110. PMID[http://www.ncbi.nlm.nih.gov/pubmed/21778118 21778118]</ref> | ||
11.<ref name="Marangoni">Marangoni A, Sambri V, Accardo S, Cavrini F, Mondardini V, Moroni A, Storni E, Cevenini R. 2006. A Decrease in the Immunoglobulin G Antibody Response Against against the VlsE Protein of ''Borrelia burgdorferi'' Sensu Lato Correlates with the Resolution of Clinical Signs in Antibiotic-Treated Patients with Early Lyme Disease. Clinical and Vaccine Immunology. 13(4): 525-529. PMID[http://www.ncbi.nlm.nih.gov/pubmed/16603623 16603623]</ref> | 11.<ref name="Marangoni">Marangoni A, Sambri V, Accardo S, Cavrini F, Mondardini V, Moroni A, Storni E, Cevenini R. 2006. A Decrease in the Immunoglobulin G Antibody Response Against against the VlsE Protein of ''Borrelia burgdorferi'' Sensu Lato Correlates with the Resolution of Clinical Signs in Antibiotic-Treated Patients with Early Lyme Disease. Clinical and Vaccine Immunology. 13(4): 525-529. PMID[http://www.ncbi.nlm.nih.gov/pubmed/16603623 16603623]</ref> | ||
12.<ref name="Eicken">Eicken C, Sharma V, Klabunde L, Lawrenz M, Hardham J, Norris S. 2002. Crystal Structure of Lyme Disease Variable Surface Antigen VlsE of ''Borrelia burgdorferi''. Journal of Biological Chemistry 277(24): 21691-21696. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11923306 11923306 ]</ref> | |||
</ref> | </ref> | ||
}} | }} | ||